Bridging Differences in Outcomes of Pharmacoepidemiological Studies: Design and First Results of the PROTECT Project
2014; Bentham Science Publishers; Volume: 9; Issue: 2 Linguagem: Inglês
10.2174/1574884708666131111211802
ISSN2212-3938
AutoresVictoria Abbing‐Karahagopian, Xavier Kurz, Frank de Vries, Tjeerd van Staa, Yolanda Escobar, Ulrik Hesse, Joerg Hasford, Liset van Dijk, Francisco J. de Abajo, J Weil, Lamiae Grimaldi‐Bensouda, Toine C. G. Egberts, Robert F. Reynolds, Olaf H. Klungel,
Tópico(s)Pharmaceutical Practices and Patient Outcomes
ResumoBackground: Observational pharmacoepidemiological (PE) studies on drug safety have produced discrepant results that may be due to differences in design, conduct and analysis. Keywords: Adrenergic beta-agonists, anti-bacterial agents, anticonvulsants, antidepressive agents, benzodiazepines, bone, calcium channel blockers, drug toxicity, european medicines agency, fractures, liver injury, myocardial infarction, neoplasms, observational studies, pharmacoepidemiology, suicide.
Referência(s)